DJIA 17,962.93 -72.00 -0.40%
NASDAQ 5,019.02 24.42 0.49%
S&P 500 2,099.33 -1.07 -0.05%
market minute promo

38.63 0.51 (1.34%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ACAD $38.63 1.34%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $38.37
Previous Close $38.12
Daily Range $38.11 - $39.07
52-Week Range $17.15 - $46.48
Market Cap $3.9B
P/E Ratio -40.13
Dividend (Yield) $0.00 (0.0%)
Volume 771,426
Average Daily Volume 2,996,133
Current FY EPS -$1.02

Sector

Healthcare

Industry

Drug Makers

ACADIA Pharmaceuticals, Inc. (ACAD) Description

The Company is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule drugs for the treatment of central nervous system disorders. Website: http://www.acadia-pharm.com/

News & Commentary

3 Stocks That Could Double Your Money

These three companies have the potential to double their share price from current levels. Here's why.

Benzinga's Top Initiations

Acadia Will Outperform, Worth $48/Share Says Leerink

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Apple, Coach, Etsy, Intel, MannKind, Netflix, S

Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Apple, Coach, Etsy, Intel, MannKind, Netflix, SanDisk, Starbucks and More

Health Care Sector Update for 04/16/2015: ACAD, RCPT, HZNP

Acadia Pharmaceuticals Could See A Big Breakthrough - Cramer's Lightning Round (4/14/15)

'Mad Money' Lightning Round: Buy, Buy, Buy Whole Foods Markets

A Recent IPO With A Medical Breakthrough For Blindness Worth Billions

Should AbbVie, Inc. Buy Acadia Pharmaceuticals to Help Fight Parkinson's Disease?

AbbVie is reportedly still interested in acquiring additional assets to help it over the Humira patent cliff hump. Would Acadia Pharmaceuticals be a good match for this big pharma?

MEI Pharma Is Undervalued By At Least Half And Will Recover, Here Is Why

See More ACAD News...

ACAD's Top Competitors

ACAD $38.63 (1.34%)
Current stock: ACAD
AMGN $167.64 (1.01%)
Current stock: AMGN
GILD $105.55 (4.86%)
Current stock: GILD
BIIB $421.73 (-0.28%)
Current stock: BIIB